Showing results (151-160 of 330) with videos related to
Sort By:
Pageof 33
European Journal of Cancer (Oxford, England : 1990)|June 16, 2018
Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 studyGertraud Stocker, Ulrich T Hacker, Frédéric Fiteni, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 30, 2006
PET imaging with [18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancerHinrich A Wieder, Hans Geinitz, Robert Rosenberg, et al.Journal of Pain and Symptom Management|August 14, 2016
Death-Related Anxiety in Patients With Advanced Cancer: Validation of the German Version of the Death and Dying Distress ScaleDorit Engelmann, Katharina Scheffold, Michael Friedrich, et al.Clinical Colorectal Cancer|December 17, 2005
Phase I/II dose-escalation study of pemetrexed plus irinotecan in patients with advanced colorectal cancerHoward Hochster, Erika Kettner, Hendrik Kroning, et al.Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|July 13, 2013
Prognostic and putative predictive biomarkers of gastric cancer for personalized medicineViktoria S Warneke, Hans-Michael Behrens, Jochen Haag, et al.Expert Review of Anticancer Therapy|August 19, 2017
Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international facultyEva Segelov, Florian Lordick, David Goldstein, et al.BMC Cancer|February 5, 2014
A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patientsSusanne Blank, Sivaramakrishna Rachakonda, Gisela Keller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2006
Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junctionKatja Ott, Wolfgang A Weber, Florian Lordick, et al.Journal of Medical Internet Research|April 25, 2024
Digital Therapeutic (Mika) Targeting Distress in Patients With Cancer: Results From a Nationwide Waitlist Randomized Controlled TrialFranziska Springer, Ayline Maier, Michael Friedrich, et al.Oncoimmunology|August 26, 2021
PD-1 inhibition in patient derived tissue cultures of human gastric and gastroesophageal adenocarcinomaMarlon Hußtegge, Ngoc Anh Hoang, Jakob Rebstock, et al.Pageof 33